Literature DB >> 11146223

Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1).

P Ader1, M Blöck, S Pietzsch, S Wolffram.   

Abstract

Recently it has been postulated that flavonoid glucosides may be absorbed by the small intestine via the SGLT-1. Therefore, we applied an in vitro mucosal uptake method to investigate mucosal uptake of the non-metabolisable glucose analogue methyl-alpha-D-glucopyranoside (MDG) as influenced by quercetin-3-glucoside (isoquercitrin) and quercetin-4'-glucoside (spiraeosid). We found that both glucosides significantly inhibited SGLT-1-mediated MDG uptake whereas the aglycon quercetin or the quercetin-3-rhamnoglucoside (rutin) were ineffective. Calculated apparent kinetic parameters (Km, Vmax) of initial Na+-dependent MDG uptake by the jejunal mucosa indicate a competitive type of inhibition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11146223     DOI: 10.1016/s0304-3835(00)00645-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Flavonoids and age-related disease: risk, benefits and critical windows.

Authors:  J K Prasain; S H Carlson; J M Wyss
Journal:  Maturitas       Date:  2010-02-23       Impact factor: 4.342

Review 2.  Naturally Occurring SGLT2 Inhibitors: A Review.

Authors:  Habib Yaribeygi; Milad Ashrafizadeh; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Transport of quercetin di-sodium salt in the human intestinal epithelial Caco-2 cell monolayer 139.

Authors:  H A Milane; A Al Ahmad; M Naitchabane; T F Vandamme; L Jung; G Ubeaud
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jul-Sep       Impact factor: 2.441

4.  Serum glucose and malondialdehyde levels in alloxan induced diabetic rats supplemented with methanolic extract of tacazzea apiculata.

Authors:  M Y Gwarzo; J H Ahmadu; M B Ahmad; A U A Dikko
Journal:  Int J Biomed Sci       Date:  2014-12

5.  Effects of dietary polyphenol-rich plant products from grape or hop on pro-inflammatory gene expression in the intestine, nutrient digestibility and faecal microbiota of weaned pigs.

Authors:  Anja Fiesel; Denise K Gessner; Erika Most; Klaus Eder
Journal:  BMC Vet Res       Date:  2014-09-04       Impact factor: 2.741

6.  Potential of Moringa oleifera to Improve Glucose Control for the Prevention of Diabetes and Related Metabolic Alterations: A Systematic Review of Animal and Human Studies.

Authors:  Esther Nova; Noemí Redondo-Useros; Rosa M Martínez-García; Sonia Gómez-Martínez; Ligia E Díaz-Prieto; Ascensión Marcos
Journal:  Nutrients       Date:  2020-07-10       Impact factor: 5.717

7.  A Phase I Dose Escalation Study Demonstrates Quercetin Safety and Explores Potential for Bioflavonoid Antivirals in Patients with Chronic Hepatitis C.

Authors:  Nu T Lu; Catherine M Crespi; Natalie M Liu; James Q Vu; Yasaman Ahmadieh; Sheng Wu; Sherry Lin; Amy McClune; Francisco Durazo; Sammy Saab; Steven Han; David C Neiman; Simon Beaven; Samuel W French
Journal:  Phytother Res       Date:  2015-12-01       Impact factor: 5.878

8.  Effects of Oral Administration of Moringa oleifera Lam on Glucose Tolerance in Goto-Kakizaki and Wistar Rats.

Authors:  Moussa Ndong; Mariko Uehara; Shin-Ichi Katsumata; Kazuharu Suzuki
Journal:  J Clin Biochem Nutr       Date:  2007-05       Impact factor: 3.114

9.  Quercitrin from Toona sinensis (Juss.) M.Roem. Attenuates Acetaminophen-Induced Acute Liver Toxicity in HepG2 Cells and Mice through Induction of Antioxidant Machinery and Inhibition of Inflammation.

Authors:  Van-Long Truong; Se-Yeon Ko; Mira Jun; Woo-Sik Jeong
Journal:  Nutrients       Date:  2016-07-15       Impact factor: 5.717

10.  Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Mao-Bing Chen; Rui-Jun Xu; Qi-Han Zheng; Xu-Wen Zheng; Hua Wang
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.